Hypertension Stocks List

Hypertension Stocks Recent News

Date Stock Title
Jul 5 PFE Executive reshuffles: NIO, Pfizer and Spirit Airlines in focus
Jul 5 AZN AstraZeneca & Aptamer partner to bolster targeted siRNA therapies
Jul 5 ABT DexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs
Jul 5 PFE Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code
Jul 5 AZN AstraZeneca’s Tagrisso plus chemotherapy wins EU approval for NSCLC
Jul 5 AZN AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
Jul 5 AZN Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Jul 5 EHAB AREX Capital Expresses Disappointment in Enhabit’s Continued Excuses and Empty Promises
Jul 5 PFE Pfizer names former State Street CEO Taraporevala to board
Jul 5 AZN Investors in AstraZeneca (LON:AZN) have seen strong returns of 115% over the past five years
Jul 5 AZN What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
Jul 5 PFE 3 Dividend Stocks That Are Screaming Buys in July
Jul 4 ABT Is Abbott Laboratories (ABT) a Good Dividend Growth Stock to Buy and Hold According to Hedge Funds?
Jul 4 PFE Pfizer Inc. (NYSE:PFE) is favoured by institutional owners who hold 68% of the company
Jul 3 PFE GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
Jul 3 PFE Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?
Jul 3 MDT Health Care Stocks With A Long History Of Dividend Growth And Solid Yields
Jul 3 PFE Health Care Stocks With A Long History Of Dividend Growth And Solid Yields
Jul 3 PFE GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
Jul 3 PFE Update: Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
Hypertension

Hypertension (HTN or HT), also known as high blood pressure (HBP), is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. High blood pressure typically does not cause symptoms. Long-term high blood pressure, however, is a major risk factor for coronary artery disease, stroke, heart failure, atrial fibrillation, peripheral vascular disease, vision loss, chronic kidney disease, and dementia.High blood pressure is classified as either primary (essential) high blood pressure or secondary high blood pressure. About 90–95% of cases are primary, defined as high blood pressure due to nonspecific lifestyle and genetic factors. Lifestyle factors that increase the risk include excess salt in the diet, excess body weight, smoking, and alcohol use. The remaining 5–10% of cases are categorized as secondary high blood pressure, defined as high blood pressure due to an identifiable cause, such as chronic kidney disease, narrowing of the kidney arteries, an endocrine disorder, or the use of birth control pills.Blood pressure is expressed by two measurements, the systolic and diastolic pressures, which are the maximum and minimum pressures, respectively. For most adults, normal blood pressure at rest is within the range of 100–130 millimeters mercury (mmHg) systolic and 60–80 mmHg diastolic. For most adults, high blood pressure is present if the resting blood pressure is persistently at or above 130/80 or 140/90 mmHg. Different numbers apply to children. Ambulatory blood pressure monitoring over a 24-hour period appears more accurate than office-based blood pressure measurement.Lifestyle changes and medications can lower blood pressure and decrease the risk of health complications. Lifestyle changes include weight loss, physical exercise, decreased salt intake, reducing alcohol intake, and a healthy diet. If lifestyle changes are not sufficient then blood pressure medications are used. Up to three medications can control blood pressure in 90% of people. The treatment of moderately high arterial blood pressure (defined as >160/100 mmHg) with medications is associated with an improved life expectancy. The effect of treatment of blood pressure between 130/80 mmHg and 160/100 mmHg is less clear, with some reviews finding benefit and others finding unclear benefit. High blood pressure affects between 16 and 37% of the population globally. In 2010 hypertension was believed to have been a factor in 18% of all deaths (9.4 million globally).

Browse All Tags